The National Institute of Standards and Technology’s Artificial Intelligence Safety Institute is seeking information on the development of chemical and biology-focused artificial intelligence models.
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, today launches its first set of muscle cell disease model products designed to advance the discovery and ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce ...
OpenAI is bragging that its forthcoming models are so advanced, they may be capable of building brand-new bioweapons. In a recent blog post, the company said that even as it builds more and more ...
Pharmaceutical Technology on MSN
Inductive Bio gains $21m ARPA-H funds for drug prediction models
New York City-based tech company Inductive Bio has secured up to $21m from the US Advanced Research Projects Agency for Health (ARPA-H) to lead the development of AI drug toxicity prediction models, ...
Cedars-Sinai investigators have created the most bio-realistic and complex computer models of individual brain cells - in unparalleled quantity. Their research, published today in the peer-reviewed ...
Bit Bio Ltd. has announced the addition to its portfolio of ioGlutamatergic Neurons MAPT N279K and ioGlutamatergic Neurons MAPT P301S disease models for frontotemporal dementia (FTD), and early access ...
The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback